Llwytho...
Residual inflammatory risk after contemporary lipid lowering therapy
BACKGROUND: Recently, there has been an increasing interest in targeting inflammation to reduce major adverse cardiovascular events (MACE) in patients with cardiovascular risk. Statins, PCSK9 inhibitors, and ezetimibe have been shown to reduce MACE owing to reduction in low-density lipoproteins chol...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Eur Heart J Qual Care Clin Outcomes |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850089/ https://ncbi.nlm.nih.gov/pubmed/31609450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjqcco/qcz055 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|